5 Followers on Owler

Celsius Therapeutics

Celsius translates single-cell genomic insights into therapeutics for the treatment of autoimmune diseases and cancer. Read more

Tariq Kassum's photo - President & CEO of Celsius Therapeutics

President & CEO

Tariq Kassum

CEO Approval Rating

90/100

Founded:

2018

Status:

PrivateIndependent Company

CELSIUS THERAPEUTICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Lycera is one of Celsius Therapeutics's top rivals. Lycera is a Private company that was founded in 2006 in Ann Arbor, Michigan. Lycera competes in the Health Care Technology industry. Compared to Celsius Therapeutics, Lycera has 3 fewer employees.

Cyteir is seen as one of Celsius Therapeutics's biggest rivals. Cyteir was founded in 2012 in Lexington, Massachusetts. Like Celsius Therapeutics, Cyteir also works within the Biotechnology field. Cyteir generates $900K less revenue than Celsius Therapeutics.

Kineta is one of Celsius Therapeutics's top competitors. Kineta was founded in null, and its headquarters is in Seattle, Washington. Like Celsius Therapeutics, Kineta also operates in the Biotechnology sector. Kineta has 118 more employees than Celsius Therapeutics.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Adhaere Pharmaceuticals a competitor of Celsius Therapeutics?

Celsius Therapeutics Acquisitions

No recent acquisitions found related to Celsius Therapeutics

Celsius Therapeutics Funding History

Since Celsius Therapeutics was founded in 2018, it has participated in 1 round of funding. In total Celsius Therapeutics has raised $65.0M. Celsius Therapeutics' funding round was on May 2018 for a total of $65.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
May 2018
$65M

Third Rock Ventures

Since Celsius Therapeutics was founded in 2018, it has participated in 1 round of funding. In total Celsius Therapeutics has raised $65.0M. Celsius Therapeutics' funding round was on May 2018 for a total of $65.0M

Celsius Therapeutics Investments

No recent investments found related to Celsius Therapeutics

Celsius Therapeutics News

June 5, 2020PM360

Celsius Therapeutics Appoints New CSO

The company bringing medicines to patients with cancer, autoimmunity, and other complex diseases, bri... See more »
May 12, 2020MarketScreener

Announces Key Leadership Appointments

(marketscreener.com) Jeanne Magram, Ph.D., Appointed to Chief Scientific Officer René Russo, Pharm.D.... See more »
September 19, 2019BioSpace

Celsius Therapeutics Signs Multiple Agreements with Academic Institutions to Access Samples for the Identification of Novel Targets in Immune Checkpoint Therapy Resistance

Celsius Applying its Single-Cell Genomics Platform Across Multiple Tumor Types and Immuno-Oncology Cl... See more »
July 9, 2019BioPharma Dive

Hunting better biomarkers, J&J taps Celsius to unpack role played by single cells

A research partnership with the pharma is Celsius' first since launching in 2018 with $65 million in ... See more »
July 9, 2019The Pharma Letter

BRIEF-Celsius and J&J embark on R&D collaboration

Celsius Therapeutics has inked an R&D deal with Johnson & Johnson's biotech arm, Janssen Biotech, to.... See more »

Celsius Therapeutics Press Releases

Social Media

Celsius Therapeutics Headquarters

399 Binney Street

Cambridge, Massachusetts02139

857-776-7400

Driving Directions »

Trending Companies

Celsius Therapeutics Summary

ABOUT

Overview

Celsius translates single-cell genomic insights into therapeutics for the treatment of autoimmune diseases and cancer. Celsius Therapeutics was founded in 2018. Celsius Therapeutics' headquarters is located in Cambridge, Massachusetts, USA 02139. It h...

CEO

Celsius Therapeutics's President & CEO, Tariq Kassum, currently has an approval rating of 90%. Celsius Therapeutics's primary competitors are Lycera, Cyteir & Kineta.

Frequently Asked Questions about Celsius Therapeutics

  1. When was Celsius Therapeutics founded?

    Celsius Therapeutics was founded in 2018
  2. Who is Celsius Therapeutics's CEO?

    Celsius Therapeutics's CEO is Tariq Kassum
  3. How much revenue does Celsius Therapeutics generate?

    Celsius Therapeutics generates $ < 1M in revenue
  4. How much funding does Celsius Therapeutics have?

    Celsius Therapeutics has historically raised $65M in funding
  1. Where is Celsius Therapeutics's headquarters?

    Celsius Therapeutics's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Celsius Therapeutics have?

    Celsius Therapeutics has 32 employees
  3. What sector does Celsius Therapeutics operate in?

    Celsius Therapeutics is in Biotechnology, Pharmaceuticals
  4. Who are Celsius Therapeutics's competitors?

    Celsius Therapeutics's top competitors are Lycera, Cyteir, Kineta